CAS: 2023788-19-2 Gip/GLP-1 Receptor Agonist Obesity Treatment Tirzepatide 10mg Raw Powder

Model NO.
2023788-19-2
Function
Keeping Health and Promoting Growth
Appearance
Powder
Purity
99.9%
Contain
5mg
CAS
2023788-19-2
Transport Package
Carton
Specification
10vials/kit
Trademark
Eusana
Origin
China
HS Code
3001200010
Production Capacity
4000000vials Per Year
Reference Price
$ 8.10 - 9.90
Contact Us

Product Description

Product Description

 

NameTirzepatide
CAS No.2023788-19-2
AppearanceRaw Powder/ Lyophilized powder
purity99%
MW4113.58000
Payment TermsAll Express Modes(EMS, DHL, TNT, FedEx, UPS,USPS, etc.) Bulk by sea or air.
Delivery Time3-5 days after we receive the payment
MFC225H348N48O68 
 

Description:

 

SEMAGLUTIDE & TIRZEPATIDE

 

GLP-1 agonists were approved by the FDA for weight loss in late 2014. It's a newer class of drugs better known for its ability to improve blood sugar control. These medications were actually designed to treat type II diabetes, but some have also been FDA approved to treat weight loss. The GLP-1 agonists we work with are called Semaglutide & Tirzepatide.

Tirzepatide is dosed at 5-15mg per week

Semaglutide is dosed at 0.5-2.4mg per week

BENEFITS OF GLP-1 AGONISTS

  • Helps slow food leaving your stomach
  • Helps prevent your liver from making too much sugar
  • Helps the pancreas produce more insul when your blood sugar levels are high
  • Can help control blood glucose
  • Can reduce hyperglycemia, especially after meals
  • Can reduce fasting insul and fasting glucose
  • Can reduce hemoglobin A1c
  • Can decrease appetite and caloric intake, while inhibiting weight gain
  • Has been shown to lower triglyceride levels and oxidative stress from high LDL
  • Has been shown to help induce weight loss in obese patients with higher dosing
  • Helps decrease leptin and increase leptin sensitivity
  • Can increase the conversion of white fat to brown fat

CAS: 2023788-19-2 Gip/GLP-1 Receptor Agonist Obesity Treatment Tirzepatide 10mg Raw PowderCAS: 2023788-19-2 Gip/GLP-1 Receptor Agonist Obesity Treatment Tirzepatide 10mg Raw PowderCAS: 2023788-19-2 Gip/GLP-1 Receptor Agonist Obesity Treatment Tirzepatide 10mg Raw Powder
Our Promise To You:
  • Every product we sell is 100 %Authentic & Top Quality.
  • Your Satisfaction is 100% Guaranteed or your money back.
Shipping:  
  • UK Overnight Delivery.
  • Express and Expedite Shipping Available

CAS: 2023788-19-2 Gip/GLP-1 Receptor Agonist Obesity Treatment Tirzepatide 10mg Raw Powder

Company profile
Wuhan Omeina Technology Co., Ltd. Was established in 2023. It is mainly engaged in peptide products, synthetic peptide amino acids, beauty and body slimming products, pharmaceutical raw materials and fine chemicals. It has strong research and development capabilities, superb synthesis technology, and advanced quality control methods. Effectively promote joint ventures and cooperation with major enterprises and manufacturers, and serve the society and users with the concept of industrial development. We always adhere to the market demand-oriented, and constantly synthesize new high-tech chemical products and pharmaceutical intermediates, mainly exported to the United States, Europe, South Africa, Nigeria and other countries and regions. We have rich export experience to ensure transportation safety, so that every customer Receive the goods safely as soon as possible.

CAS: 2023788-19-2 Gip/GLP-1 Receptor Agonist Obesity Treatment Tirzepatide 10mg Raw Powder
CAS: 2023788-19-2 Gip/GLP-1 Receptor Agonist Obesity Treatment Tirzepatide 10mg Raw PowderCAS: 2023788-19-2 Gip/GLP-1 Receptor Agonist Obesity Treatment Tirzepatide 10mg Raw Powder

 

Biochemical

PNEUTEC.IT, 2023